A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

NCT01725308 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: FK949E
DRUG: Placebo

Sponsor

Astellas Pharma Inc